Actively Recruiting
Observational Study to Understand Charcot-Marie-Tooth Disease and Related Disorders in China
Led by Ning Wang, MD., PhD. · Updated on 2022-01-11
500
Participants Needed
1
Research Sites
521 weeks
Total Duration
AI-Summary
What this Trial Is About
This research aims to analyze natural history data from patients with Charcot-Marie-Tooth disease and related disorders in China. It focuses on assessing clinical, genetic, and epigenetic features to better understand the condition and improve clinical management. The study is observational and gathers detailed information to support patient care optimization. Participants include patients clinically or genetically diagnosed with Charcot-Marie-Tooth disease and unrelated healthy controls. The study collects data over time to observe disease progression and characteristics without administering any treatments or interventions. Throughout the study, researchers will monitor changes in the Charcot-Marie-Tooth Neuropathy Score CMTNS over up to six months. Participants will undergo assessments that help track the diseases impact and progression. The study is open to all genders and ages, with voluntary participation and long-term observation planned until the study end date in 2049.
CONDITIONS
Brief Title
A Registered Cohort Study on Charcot-Marie-Tooth Disease
Research Team
N
Ning Wang, MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
